Table 3 Number (%) of Criteria Resulting in Ineligibility for Trials
From: Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
No of Criteria | No of Patients E1594 | No of Patients SWOG9509 | ||||
|---|---|---|---|---|---|---|
Resulting in Ineligibility | Prospective Data N = 100 (%) | Retrospective Data N = 85 (%) | Entire Cohort N = 185(%) | Prospective Data N = 100 (%) | Retrospective Data N = 85 (%) | Entire Cohort N = 185 (%) |
1 | 32 (32%) | 38 (45%) | 71 (38%) | 34 (34%) | 41 (48%) | 75 (40.5%) |
2 | 22 (22%) | 11 (13%) | 33 (18%) | 23 (23%) | 12 (14%) | 35 (19%) |
3 | 6 (6%) | 9 (11%) | 15 (8%) | 7 (7%) | 11 (13%) | 18 (10%) |
4 | 1 (1%) | 2 (2%) | 3 (2%) | 2 (2%) | 2 (2%) | 4 (2%) |